Skip to main content

Reporter Feb 25 2022

Probing cancer cell invasion

Mar. 1, 2022—The rigidity of the extracellular matrix that surrounds cells impacts the contractile and invasive properties of head and neck cancer cells.

Read more


Invasive strep can defy zinc toxicity

Feb. 28, 2022—Vanderbilt researchers find that invasive Group B Streptococcus strains, a significant risk to pregnant patients and infants, can grow in presence of toxic zinc levels.

Read more


PET imaging probe for Alzheimer’s disease

Feb. 24, 2022—Vanderbilt researchers report on a new PET imaging probe that will be useful for exploring Alzheimer’s disease pathology.

Read more


Melanoma treatment response

Feb. 24, 2022—Targeting the interaction between melanoma and immune cells could improve responses to targeted cancer therapies, Vanderbilt researchers found.

Read more


Ahonkhai advances in national challenge to improve HIV care for Black men in Tennessee

Feb. 24, 2022—A Vanderbilt proposal to implement a novel strategy to use barbers and barbershops to improve HIV care outcomes for Black men with HIV in Middle Tennessee received early-stage funding from a challenge hosted by the U.S. Department of Health and Human Services’ Office of Minority Health.

Read more


MIS-C diagnosis rare in vaccinated children with no previous COVID-19 diagnosis

Feb. 24, 2022—A Vanderbiltl study found that children who received the COVID-19 vaccine who had not previously been diagnosed with COVID infection are unlikely to be diagnosed with multisystem inflammatory syndrome in children (MIS-C).

Read more


Capacity building activities and new curriculum strengthen medical education in Liberia

Feb. 24, 2022—Liberia's fragile health system is being strengthened through U.S.-Liberia partnerships focused on medical education and capacity building at the country's only medical school, A.M. Dogliotti (AMD) School of Medicine in the College of Health Sciences at the University of Liberia.

Read more


Spinal cord stimulator implants helping ease chronic pain

Feb. 24, 2022—Specialists at Vanderbilt University Medical Center implanted 130 spinal cord stimulators last year to help ease patients' chronic pain.

Read more


VUMC researchers find clue to drug-induced arrhythmias

Feb. 24, 2022—Vanderbilt University Medical Center researchers have made a fundamental discovery about how the heart compensates for genetic variations that otherwise could trigger abnormal and potentially fatal heart rhythms.

Read more


Heart/liver transplant gives congenital heart disease patient new hope

Feb. 24, 2022—Last year, Liz Barnett became one of seven people at Vanderbilt University Medical Center to receive a combined heart/liver transplant in 2021.

Read more


Study to explore neurologic impact of flu treatment

Feb. 24, 2022—A Vanderbilt study will explore the neurologic and psychiatric complications of flu and evaluate adverse effects of the antiviral treatment oseltamivir, also known by the brand name Tamiflu.

Read more


VUMC’s Smith elected to AIMBE College of Fellows

Feb. 24, 2022—Vanderbilt's Seth Smith, PhD, has been elected to the College of Fellows of the American Institute for Medical and Biological Engineering.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more